NASDAQ · Biotechnology

Geron Corporation (GERN)

$0.89 -5.47%
Add alert See all oversold stocks →
22 Oversold Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 200$1.44-37.89%

Company profile

Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California.

SectorHealthcare
IndustryBiotechnology
Market cap$783.82M
P/E ratioNone
EPS$-0.11
Beta0.611
Dividend yield0.00%
52-week high$2.01
52-week low$1.04

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 41 VRTX Vertex Pharmaceuticals Inc RSI 68 CRSP CRISPR Therapeutics AG RSI 48 IOVA Iovance Biotherapeutics Inc RSI 30 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 52 CADL Candel Therapeutics Inc RSI 38 ARDX Ardelyx Inc RSI 37 ANRO Alto Neuroscience Inc RSI 40 ALT Altimmune Inc RSI 27 ALLO Allogene Therapeutics Inc RSI 29
30 days of PRO Unlimited free, no card

RSI alerts for GERN

An email when GERN closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 13 October 2026 at 10:33 PM EDT